Global Blood Glucose Monitoring Devices Market 2017-2021

  • ID: 4115503
  • Report
  • Region: Global
  • 86 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton Dickinson
  • Dexcom
  • International Biomedical
  • MediWise
  • Nemaura
  • MORE
About Blood Glucose Monitoring Devices

The global BGM devices market is growing due to the increase in the number of people with diabetes, especially type 1 diabetes. To avoid high doses of medication and insulin intake, these people are moving toward monitoring blood glucose levels by learning about the technicalities and the usage of BGM devices.

The analysts forecast the global blood glucose monitoring devices market to grow at a CAGR of 11.81% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global blood glucose monitoring devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of BGM devices.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Blood Glucose Monitoring Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- Abbott Laboratories
- Roche Diagnostics
- LifeScan
- Medtronic

Other prominent vendors
- AgaMatrix
- Animas
- Becton Dickinson
- Bioptik Technology
- DarioHealth
- Dexcom
- GlySens
- Integrity Applications
- International Biomedical
- Medisana
- MediWise
- Menarini Diagnosticos
- Nemaura
- Nipro Diagnostics
- Nova Biomedical
- Owen Mumford
- Senseonics
- TaiDoc Technology

Market drivers
- Availability of reimbursement for BGM devices.
- For a full, detailed list, view the full report

Market challenges
- Inaccuracy in reading of BGM devices.
- For a full, detailed list, view the full report

Market trends
- Increased adoption of bundled product marketing strategy.
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton Dickinson
  • Dexcom
  • International Biomedical
  • MediWise
  • Nemaura
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by product

Global CGM market

Global SMBG market

Lancets

PART 07: Market segmentation by end-user

Hospitals and diagnostic laboratories

POL

Home care settings

PART 08: Geographical segmentation

BGM devices market in Americas

BGM devices market in EMEA

BGM devices market in APAC

PART 09: Market drivers

Growing prevalence of diabetes in the world

Technological advances in BGM devices

Availability of reimbursement for BGM devices

PART 10: Impact of drivers

PART 11: Market challenges

High cost of BGM devices

Intense competition among vendors

Undiagnosed population

Inaccuracy in reading of BGM devices

PART 12: Impact of drivers and challenges

PART 13: Market trends

Smart watch-based apps

Increasing adoption of home healthcare devices

Increase in online marketing strategies

Increased adoption of bundled product marketing strategy

PART 14: Vendor landscape

Competitive scenario

PART 15: Key vendor analysis

Abbott Laboratories

Roche Diagnostics

LifeScan

Medtronic

Key companies to watch

Other prominent vendors

PART 16: Appendix

List of abbreviations

PART 17: About the Author

List of Exhibits
Exhibit 01: Evolution of CGM devices
Exhibit 02: Product offerings
Exhibit 03: Global BGM devices market: Overview
Exhibit 04: Global BGM devices market 2016-2021 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Global BGM devices segments analysis 2016
Exhibit 07: Global CGM market share 2016
Exhibit 08: Global glucose monitors market share 2016
Exhibit 09: Factors considered while purchasing a blood glucose meter
Exhibit 10: Global CGM market 2016-2021 ($ billions)
Exhibit 11: Market metrics analysis of CGM devices
Exhibit 12: Global CGM transmitters and receivers market 2016-2021 ($ millions)
Exhibit 13: Global CGM glucose sensors market 2016-2021 ($ millions)
Exhibit 14: Global insulin pumps market 2016-2021 ($ billions)
Exhibit 15: Global SMBG market: Strength and weakness
Exhibit 16: Global SMBG market 2016-2021 ($ billions)
Exhibit 17: Market metrics analysis of SMBG devices
Exhibit 18: Global SMBG test strips market 2016-2021 ($ billions)
Exhibit 19: Global SMBG meters market 2016-2021 ($ billions)
Exhibit 20: Product matrix for lancets
Exhibit 21: Product matrix for lancing devices
Exhibit 22: Global lancets market 2016-2021 ($ millions)
Exhibit 23: Market analysis of lancets
Exhibit 24: Global BGM devices market by end-user 2016
Exhibit 25: Various types of reference measurement services
Exhibit 26: Important aspects of a home care BGM device
Exhibit 27: Global BGM devices market by geography
Exhibit 28: Global BGM devices market by geography ($ billions)
Exhibit 29: BGM devices market overview in Americas 2016
Exhibit 30: BGM devices market in Americas 2016-2021 ($ billions)
Exhibit 31: BGM devices market overview in EMEA 2016
Exhibit 32: BGM devices market in EMEA 2016-2021 ($ billions)
Exhibit 33: Market scenarios in selected European countries
Exhibit 34: BGM devices market overview in APAC 2016
Exhibit 35: BGM devices market in APAC 2016-2021 ($ billions)
Exhibit 36: Medtronic partnerships in different countries
Exhibit 37: Impact of drivers
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Features of apps based on smart watch
Exhibit 40: Global BGM devices market: Vendor ranking 2016
Exhibit 41: Global BGM devices market: Competitive structure analysis 2016
Exhibit 42: Global BGM devices market-competitive landscape
Exhibit 43: Strategic success of companies
Exhibit 44: Abbott Diagnostics: Strength assessment
Exhibit 45: Abbott Diagnostics: Strategy assessment
Exhibit 46: Abbott Diagnostics: Opportunity assessment
Exhibit 47: Roche Diagnostics: Strength assessment
Exhibit 48: Roche Diagnostics: Strategy assessment
Exhibit 49: Roche Diagnostics: Opportunity assessment
Exhibit 50: LifeScan: Strength assessment
Exhibit 51: LifeScan: Strategy assessment
Exhibit 52: LifeScan: Opportunity assessment
Exhibit 53: Medtronic: Strength assessment
Exhibit 54: Medtronic: Strategy assessment
Exhibit 55: Medtronic: Opportunity assessment
Exhibit 56: Ypsomed: Company overview
Exhibit 57: B Braun: Company overview
Exhibit 58: Arkray company overview
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton Dickinson
  • Dexcom
  • International Biomedical
  • MediWise
  • Nemaura
  • MORE
New Report Released: – Global Blood Glucose Monitoring Devices Market 2017-2021

The author of the report recognizes the following companies as the key players in the global blood glucose monitoring devices market: Abbott Laboratories, Roche Diagnostics, LifeScan, and Medtronic.

Other Prominent Vendors in the market are: AgaMatrix, Animas, Becton Dickinson, Bioptik Technology, DarioHealth, Dexcom, GlySens, Integrity Applications, International Biomedical, Medisana, MediWise, Menarini Diagnosticos, Nemaura, Nipro Diagnostics, Nova Biomedical. Owen Mumford, Senseonics, and TaiDoc Technology.

Commenting on the report, an analyst from the research team said: “One trend in market is smart watch-based apps. The Dexcom CGM and its mobile apps Follow and Share 2 are the first mobile-connected systems approved by the US FDA. This device allows users to directly view the glucose data on their iPhone. Currently, Dexcom provides its devices G4 platinum CGM with Share that supports the Apple watch. Along with this, the users can invite up to five people to view their glucose information, and an alert message can be sent when the user's glucose levels are above normal range. This is a significant breakthrough in diabetes management. The use of glucose meters is supplemented by CGM devices in diabetes management. Meters still play a major role in calibrating CGM devices and in guiding therapy and meal decisions. In addition to providing the glucose levels, CGM devices provide the direction and rate of change in glucose levels with the push of a button and alerts users when the glucose level is too low or too high.”

According to the report, one driver in market is growing prevalence of diabetes in the world. In 2015, approximately 415 million people in the world had diabetes, which is expected to increase to around 642 million by 2040. As of 2015, it has been estimated that 9.1% adults in the world have diabetes and this is expected to increase to 10% by 2040. In addition, 75%-80% of the individuals with diabetes belonged to low- and middle-income countries. The number of people with diabetes is high in APAC. According to OECD, the prevalent cases are going to reach about 47,973,000 in Europe, 66,812,000 in the Americas, and 18,234,000 in Africa by 2030. The global prevalence of diabetes was estimated to be 9% among adults aged above 18 years.

Further, the report states that one challenge in market is high cost of BGM devices. The high cost of BGM devices is a major challenge hindering the growth of the global BGM devices market. Most invasive BGM devices are both painful as they use a lancet to prick the fingertip to extract blood required for testing. They are also expensive due to the consumable test strips that are needed to test the blood. So, many diabetic patients are reluctant to adopt BGM devices and do not monitor their blood glucose levels as often as they should. Moreover, calibration of the BGM systems is also very expensive. So, despite the numerous benefits, the high cost of BGM devices hinders their acceptance among patients. The average price of lancing devices ranges from $30 to $35 in most countries.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott Laboratories
  • Roche Diagnostics
  • LifeScan
  • Medtronic
  • AgaMatrix
  • Animas
  • Becton Dickinson
  • Bioptik Technology
  • DarioHealth
  • Dexcom
  • GlySens
  • Integrity Applications
  • International Biomedical
  • Medisana
  • MediWise
  • Menarini Diagnosticos
  • Nemaura
  • Nipro Diagnostics
  • Nova Biomedical Owen Mumford
  • Senseonics
  • TaiDoc Technology
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll